Department of Endocrinology, Lilavati and Bhatia Hospital and Grant Medical College, Mumbai, India.
Diabetes Technol Ther. 2012 Jan;14(1):8-15. doi: 10.1089/dia.2011.0243. Epub 2011 Nov 3.
Despite the rising number of patients with diabetes and hypertension in India, there is a dearth of nationwide, comprehensive prevalence data on these diseases. Our study aimed at collecting data on the prevalence of diabetes and hypertension and the underlying risk factors in various outpatient facilities throughout India.
This cross-sectional study was planned to be conducted in 10 Indian states, one state at a time. It was targeted to enroll about 2,000 patients from 100 centers in each state. Each center enrolled the first 10 patients (≥18 years of age, not pregnant, signed consent) per day on two consecutive days. "Diabetes" and "hypertension" were defined by the 2008 American Diabetes Association and the Joint National Committee's 7(th) Report guidelines, respectively. Patient data (demographics, lifestyle factors, medical history, and laboratory diagnostic results) were collected and analyzed.
During 2009-2010, in total, 15,662 eligible patients (54.8% males; mean age, 48.9±13.9 years) from eight states were enrolled. Diabetes was prevalent in 5,427 (34.7%) patients, and 7,212 (46.0%) patients had hypertension. Diabetes and hypertension were coexistent in 3,227 (20.6%) patients. Among those whose disease status was not known at enrollment, 7.2% (793 of 11,028) and 22.2% (2,408 of 10,858) patients were newly diagnosed with diabetes and hypertension, respectively; additionally, 18.4% (2,031 of 11,028) were classified as having prediabetes and 60.1% (6,521 of 10,858) as having prehypertension. A positive association (P<0.05) was observed between diabetes/hypertension and age, familial history of either, a medical history of cardiovascular disorders, alcohol consumption, and diet.
Our study demonstrates that the substantial burden of diabetes and hypertension is on the rise in India. Patient awareness and timely diagnosis and intervention hold the key to limiting this twin epidemic.
尽管印度的糖尿病和高血压患者人数不断增加,但缺乏全国范围内此类疾病的综合患病率数据。我们的研究旨在收集印度各地各种门诊设施中糖尿病和高血压的患病率和潜在危险因素的数据。
这项横断面研究计划在印度的 10 个邦进行,一次一个邦。它的目标是在每个邦的 100 个中心招募约 2000 名患者。每个中心在连续两天的每天前 10 名(年龄≥18 岁,非孕妇,签署同意书)患者入组。“糖尿病”和“高血压”分别按照 2008 年美国糖尿病协会和联合国家委员会第 7 次报告指南进行定义。收集并分析患者数据(人口统计学、生活方式因素、病史和实验室诊断结果)。
在 2009-2010 年期间,总共在 8 个邦招募了 15662 名符合条件的患者(54.8%为男性;平均年龄为 48.9±13.9 岁)。5427 名(34.7%)患者患有糖尿病,7212 名(46.0%)患者患有高血压。3227 名(20.6%)患者同时患有糖尿病和高血压。在入组时不知道疾病状况的患者中,分别有 7.2%(793/11028)和 22.2%(2408/10858)的患者新诊断为糖尿病和高血压,此外,18.4%(2031/11028)患者被归类为糖尿病前期,60.1%(6521/10858)患者被归类为高血压前期。糖尿病/高血压与年龄、家族史、心血管疾病史、饮酒和饮食呈正相关(P<0.05)。
我们的研究表明,印度糖尿病和高血压的负担正在增加。患者的意识以及及时的诊断和干预是控制这一双重流行的关键。